LSP closes latest fund

The Amsterdam, Netherlands-based manager has raised one of the largest life sciences funds.

  • Fund name: Life Sciences Partners VI (LSP 6)
  • Amount raised: $600 million
  • Target size: $450 million
  • Hard-cap: $600 million
  • Stage of fundraising: Final close
  • Final close date: March 2020
  • Predecessor fund: Life Sciences Partners V (LSP 5) ($280 million)

Life Science Partners has closed its latest fund at its $600 million hard-cap. Life Sciences Partners VI (LSP 6) will follow the investment strategy of its predecessor funds investing in 15-18 predominantly European private companies developing new medications or medical technologies.